K Aiba is an author at Mitsubishi Group (Japan) specializing in pharmacology, oncology, and cancer therapeutics.
Top concepts
HealthMedicineOncologyPharmacologyBreast CancerCancer TherapyDrug DiscoveryCancer ResearchDrug ResistancePharmacotherapy
Publications per year
1999–2003
2
2
Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug.
Keiji Hirata, N Horikoshi, K Aiba et al. · PubMed · 1999 · 227 citations
Rows per page
1–2 of 2